Status:
UNKNOWN
Evaluation of Clinical Efficacy of Different Injection Therapies for Treating Humeral Epicondylopathy
Lead Sponsor:
Wroclaw Medical University
Conditions:
Elbow Tendinopathy
Eligibility:
All Genders
30-60 years
Phase:
PHASE4
Brief Summary
Humeral epicondylopathies are common disorders which can significantly impair upper limb function. In case of failure of rehabilitation protocol there is no evidence based second line therapy. It is c...
Detailed Description
The study will be a single-center, prospective, randomized, double-blinded, controlled trial with placebo. It is planned to enroll 120 patients with lateral epicondylopathy and divide them to four equ...
Eligibility Criteria
Inclusion
- pain on the lateral side of the elbow joint for at least three months,
- confirmation of lateral epicondylitis in at least one provocative test,
- no previous invasive treatment,
- no improvement after rehabilitation
Exclusion
- nervous system diseases related to the upper limb,
- hematological diseases,
- diabetes,
- tumors of upper extremity,
- gout,
- advanced osteoarthritis,
- previously performed operations around the elbow joint,
- suspicion of the infectious process,
- pregnant
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04521387
Start Date
February 1 2021
End Date
May 31 2022
Last Update
March 11 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sport Division, Wroclaw Medical University
Wroclaw, Woj. Dolnośląskie, Poland, 51-618